2003
DOI: 10.1016/s0195-668x(03)93961-3
|View full text |Cite
|
Sign up to set email alerts
|

P523 Sirolimus-eluting stents for the treatment of unprotected left main coronary lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2005
2005

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Furthermore, the recently published E-SIRIUS trial demonstrated even lower rates of restenosis than did the SIRIUS trial (5.1% vs 8.9%). 31 Recently, Suárez et al 32 presented the first series of patients with unprotected left main coronary artery lesions treated with drug-eluting stents. Forty-seven patients underwent stenting with a sirolimus-eluting stent.…”
Section: Drug-eluting Stentsmentioning
confidence: 99%
“…Furthermore, the recently published E-SIRIUS trial demonstrated even lower rates of restenosis than did the SIRIUS trial (5.1% vs 8.9%). 31 Recently, Suárez et al 32 presented the first series of patients with unprotected left main coronary artery lesions treated with drug-eluting stents. Forty-seven patients underwent stenting with a sirolimus-eluting stent.…”
Section: Drug-eluting Stentsmentioning
confidence: 99%